Employers are projecting a median 10% increase in healthcare costs for 2026, driven largely by high claims and specialty drug ...

Novo Nordisk’s GLP-1 drug Wegovy expanded its label to include the metabolic disorder known as MASH. Analysts say there’s ...

You don’t have to practice in Florida for this law to matter. Patient interest in regenerative care is growing rapidly, and ...

The Trump administration is directing the Department of Health and Human Services to identify about 26 “critical medicines.” ...

Response Pharmaceuticals takes a new approach to weight loss with an oral small molecule designed to inhibit a protein called iMTP to reduce uptake of fats and cholesterol. While this drug’s ...

Pfizer’s inclacumab did not beat a placebo in a Phase 3 test in sickle cell disease. The trial failure comes nearly a year after Pfizer voluntarily withdrew Oxbryta from the market after tests ...

Isaac Health, a startup specializing in cognitive care for Alzheimer’s dementia , raised $10.5 million in Series A funding to expand nationwide access to its platform. The company partners with ...